Biography:Thorsten M. Schlaeger
Thorsten M. Schlaeger, Ph.D., is the head of the Human Embryonic Stem Cell Core Facility of the Stem Cell Program at Boston Children’s Hospital.[1]
He studied Human Biology (Humanbiologie) at the University of Marburg and performed his Ph.D. thesis work in the laboratories of Werner Risau and Tom Sato.[2] In 1999 he was awarded the Otto Hahn Medal of the Max Planck Society for his Ph.D. thesis on endothelial cell specific gene expression.[3] Following his postdoctoral research in the laboratory of Stuart Orkin and a short foray into industry, he re-joined Boston Children’s Hospital where he works with Leonard I. Zon and George Q. Daley to develop induced pluripotent stem cell based transfusion and transplantation products.[2] His laboratory focuses on human pluripotent stem cell biology, genome editing, reprogramming, laboratory automation, chemical genetics, and imaging technologies.[1]
Google Scholar shows that ten of his papers have been cited more than 100 times each.[4]
References
- ↑ 1.0 1.1 "The hESC Core Facility | Boston Children's Hospital". http://stemcell.childrenshospital.org/about-us/stem-cell-program-labs/the-hesc-core-facility/.
- ↑ 2.0 2.1 "Thorsten M. Schlaeger, PhD | Boston Children's Hospital". http://stemcell.childrenshospital.org/about-us/leadership-faculty-staff/thorsten-m-schlaeger/.
- ↑ "Thorsten Schlaeger, PhD | Research + Innovation | Boston Children's Hospital". http://www.childrenshospital.org/researchers/thorsten-schlaeger.
- ↑ [1]
 |
